Split History
ETFs Holding TENX »    TENX Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Tenax Therapeutics is a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases. Through its wholly owned subsidiary, Life Newco, Inc. (Life Newco), Co. owns a license granting Life Newco a right to develop and commercialize pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion / 5ml vial in the United States and Canada. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. According to our TENX split history records, Tenax Therapeutics has had 1 split.
TENX split history picture
Tenax Therapeutics (TENX) has 1 split in our TENX split history database. The split for TENX took place on February 26, 2018. This was a 1 for 20 reverse split, meaning for each 20 shares of TENX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as Tenax Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the TENX split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Tenax Therapeutics shares, starting with a $10,000 purchase of TENX, presented on a split-history-adjusted basis factoring in the complete TENX split history. TENX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/06/2010
End date: 07/02/2020
Start price/share: $56.20
End price/share: $0.90
Dividends collected/share: $0.00
Total return: -98.39%
Average Annual Total Return: -33.85%
Starting investment: $10,000.00
Ending investment: $160.62
Years: 10.00
Date Ratio
02/26/20181 for 20
TENX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TEVA Split History
TFX Split History
TGTX Split History
TGX Split History
THC Split History
THRX Split History
TLB Split History
TLGT Split History
TMO Split History
TNDM Split History

Also explore: TENX shares outstanding history

Altus Midstream Company (ATLM)
FS KKR Capital Corp. (FSK)
Groupon (GRPN)
XpresSpa Group, Inc. (XSPA)
Energy Focus, Inc. (EFOI)
The Cushing NextGen Infrastructure Income Fund (SZC)
Teligent, Inc. (TLGT)
Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

TENX Insider Buying

TENX Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.